Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

China · Delayed Price · Currency is CNY

12.72

+0.54 (4.43%)

Oct 16, 2026, 3:04 PM CST

Market Cap	11.81B -34.4%
Revenue (ttm)	1.64B -11.8%
Net Income	197.25M -19.4%
EPS	0.21 -19.3%
Shares Out	928.16M
PE Ratio	60.61
Forward PE	n/a
Dividend	0.12 (0.94%)
Ex-Dividend Date	Jun 18, 2026

Volume	27,079,963
Open	13.34
Previous Close	12.18
Day's Range	12.18 - 13.34
52-Week Range	11.02 - 20.75
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:002755

Beijing Aosaikang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of active pharmaceutical ingredients and formulations in China. It also offers digestive health products, which include pump inhibitors suitable for various digestive tract-related diseases, such as peptic ulcers, reflux esophagitis, and upper gastrointestinal bleeding; and anti-tumor products, including the treatment of non-small cell lung cancer, colorectal cancer, and breast cancer, encompassing targeted therapy, chemotherapy, endocrine ther... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1996

Employees 799

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002755

Full Company Profile

Financial Performance

In 2025, SHE:002755's revenue was 1.78 billion, an increase of 0.08% compared to the previous year's 1.78 billion. Earnings were 236.60 million, an increase of 47.60%.

Financial Statements